Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-upNadine Abdallah,Thomas E. Witzig,Shaji K. Kumar,Martha Q. Lacy,Suzanne R. Hayman,Angela Dispenzieri,Vivek Roy,Morie A. Gertz,P. Leif Bergsagel,S. Vincent RajkumarLeukemia(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要